AUS
NZ
UK
CA
USA
IND
AMA Group Limited (ASX:AMA) has announced updates to the shareholdings of non-executive directors Brian Austin and Anthony (Tony) Clark following the allocation of Restricted Rights in lieu of director fees on 3 July 2026. Each director was granted 72,780 Restricted Rights under the company’s Non-Executive Director Equity Plan, which was approved by shareholders at the Annual General Meeting on 3 November 2025. These grants increase the Restricted Rights held by both directors without altering their ordinary shareholdings. This move highlights AMA Group’s ongoing commitment to aligning director remuneration with shareholder interests by substituting cash payments with equity-based compensation.<\/p> <\/div>
Key Points<\/h3>
- Company: AMA Group Limited (ASX:AMA)<\/li>
- Non-executive directors Brian Austin and Anthony (Tony) Clark each received 72,780 Restricted Rights on 3 July 2026<\/li>
- Restricted Rights granted in lieu of director fees under the Non-Executive Director Equity Plan, approved at the 3 November 2025 AGM<\/li>
- Brian Austin’s direct Restricted Rights increased from 54,059 to 126,839; Tony Clark’s from 19,182 to 91,962<\/li>
- Neither director acquired or disposed of ordinary shares; no cash was paid for the rights<\/li>
- Grants were made outside any closed period requiring prior clearance<\/li>
- Investors should monitor forthcoming disclosures regarding vesting or conversion of these Restricted Rights<\/li>
<\/ul>
<\/div>
Details of the 3 July 2026 Restricted Rights Grants to Directors<\/h2>
In its ASX announcement, AMA Group confirmed that both Brian Austin and Anthony Clark received 72,780 Restricted Rights each on 3 July 2026. These grants were made under the Non-Executive Director Equity Plan, which enables directors to receive fees in equity form rather than cash. The consideration for these grants was noted as not applicable, reflecting their nature as a non-cash fee substitution.<\/p>
Following the grants, Brian Austin’s total direct Restricted Rights holding rose from 54,059 to 126,839, significantly increasing his equity exposure. Tony Clark’s direct Restricted Rights increased from 19,182 to 91,962. Neither director’s indirect ordinary shareholdings changed, and no securities were sold or purchased as part of this transaction.<\/p>
Shareholder Endorsement of the Equity Plan at the 2025 AGM<\/h2>
The Restricted Rights issued on 3 July 2026 were granted pursuant to the Non-Executive Director Equity Plan, which shareholders approved at the 3 November 2025 Annual General Meeting. This approval provides the governance framework authorizing the issuance of equity-based remuneration to non-executive directors instead of cash fees, ensuring shareholder consent precedes any grants.<\/p>
Such shareholder-approved equity plans align with ASX corporate governance principles promoting transparency and oversight of director remuneration. AMA Group’s ratification of the plan at the AGM affirms the legitimacy of ongoing grants under this framework, which investors may view as a positive governance indicator.<\/p>
Brian Austin’s Security Holdings Post-Grant<\/h2>
After the 3 July 2026 grant, Brian Austin holds 126,839 Restricted Rights directly. Additionally, through Austin Superannuation Pty Ltd as trustee for the Brian Austin S\/F A\/C — a director-related entity — he holds 11,271,953 ordinary shares indirectly. This substantial indirect holding aligns his interests closely with those of AMA Group shareholders.<\/p>
The combination of direct Restricted Rights and significant indirect ordinary shares provides Austin with both long-term equity incentives and a meaningful economic stake. The company has not disclosed vesting schedules, performance conditions, or conversion ratios for the Restricted Rights, leaving their ultimate value contingent on those terms.<\/p>
Anthony Clark’s Holdings Across Multiple Entities<\/h2>
Following the grant, Tony Clark’s direct Restricted Rights increased to 91,962 from 19,182. His indirect interests include 467,356 ordinary shares held via the Clark Family Super Fund (registered to Mr Anthony James Clark and Mrs Denise Maree Clark) and 306,748 ordinary shares held through Clojack Pty Ltd operating as the Clojack Family A\/C, both director-related entities. These ordinary shareholdings remain unchanged post-grant.<\/p>
The company’s filing notes Clark’s last director interest notice was lodged on 25 June 2026, indicating frequent disclosures in recent months. Investors tracking insider activity may find this detail relevant when monitoring changes in his overall holdings.<\/p>
Functioning of AMA Group’s Non-Executive Director Equity Plan<\/h2>
The plan permits AMA Group to fulfill director fee obligations by issuing Restricted Rights instead of cash payments. This approach conserves cash resources while aligning directors’ incentives with the company’s long-term share price performance, a practice increasingly common among ASX-listed firms.<\/p>
Restricted Rights typically involve conditions such as holding locks, vesting periods, or performance hurdles before conversion to ordinary shares. The company has not disclosed specific terms for the 3 July 2026 grants, including vesting or conversion details. Interested investors should consult the plan documentation approved at the November 2025 AGM or await further company disclosures.<\/p>
Compliance With ASX Listing Rules and Disclosure Obligations<\/h2>
Both grants occurred outside any ASX-defined closed periods requiring prior written clearance, ensuring compliance with the company’s securities trading policies. The disclosures were made under ASX Listing Rule 3.19A.2 and section 205G of the Corporations Act, fulfilling AMA Group’s obligation to promptly notify changes in directors’ relevant interests.<\/p>
Implications for AMA Group’s Board Remuneration Strategy<\/h2>
The acceptance of Restricted Rights by Brian Austin and Tony Clark in lieu of cash fees, facilitated through a shareholder-approved plan, reflects a remuneration philosophy emphasizing equity ownership among non-executive directors. This alignment encourages governance decisions that benefit long-term shareholders.<\/p>
For investors, the directors’ choice of equity over cash signals confidence in AMA Group’s prospects, though the grants represent a continuation of an established remuneration framework rather than a new discretionary exposure increase.<\/p>
Context Within AMA Group’s Automotive Aftercare Operations<\/h2>
AMA Group operates in the automotive aftercare sector, focusing on vehicle collision repair services in Australia. The company has experienced strategic and operational changes recently, with non-executive director composition and remuneration under investor scrutiny. The simultaneous filing of director interest notices for Austin and Clark aligns with the company’s equity plan grant schedule.<\/p>
Investors may look to upcoming financial reports for insights into how the equity plan affects AMA Group’s cost structure and remuneration expenses. The grants represent non-cash accounting expenses impacting share-based payment disclosures. The company did not disclose the monetary value of the 3 July 2026 Restricted Rights grants.<\/p>
Looking Ahead: Vesting and Future Disclosures<\/h2>
Investors should monitor announcements regarding any vesting or conversion events related to the Restricted Rights held by Brian Austin and Tony Clark. Upon vesting, further disclosures such as Appendix 3Y notices would confirm conversion into ordinary shares, potentially increasing their shareholdings and influencing market activity.<\/p>
Additionally, future participation by other directors in the Non-Executive Director Equity Plan will indicate the plan’s broader adoption. Material amendments to the plan’s terms or grant sizes would require disclosure and possibly shareholder approval. The immediate market impact of these notices was not evident from available information.<\/p>
Details of the 3 July 2026 Restricted Rights Grants to Directors<\/h2>
In its ASX announcement, AMA Group confirmed that both Brian Austin and Anthony Clark received 72,780 Restricted Rights each on 3 July 2026. These grants were made under the Non-Executive Director Equity Plan, which enables directors to receive fees in equity form rather than cash. The consideration for these grants was noted as not applicable, reflecting their nature as a non-cash fee substitution.<\/p>
Following the grants, Brian Austin’s total direct Restricted Rights holding rose from 54,059 to 126,839, significantly increasing his equity exposure. Tony Clark’s direct Restricted Rights increased from 19,182 to 91,962. Neither director’s indirect ordinary shareholdings changed, and no securities were sold or purchased as part of this transaction.<\/p>
Shareholder Endorsement of the Equity Plan at the 2025 AGM<\/h2>
The Restricted Rights issued on 3 July 2026 were granted pursuant to the Non-Executive Director Equity Plan, which shareholders approved at the 3 November 2025 Annual General Meeting. This approval provides the governance framework authorizing the issuance of equity-based remuneration to non-executive directors instead of cash fees, ensuring shareholder consent precedes any grants.<\/p>
Such shareholder-approved equity plans align with ASX corporate governance principles promoting transparency and oversight of director remuneration. AMA Group’s ratification of the plan at the AGM affirms the legitimacy of ongoing grants under this framework, which investors may view as a positive governance indicator.<\/p>
Brian Austin’s Security Holdings Post-Grant<\/h2>
After the 3 July 2026 grant, Brian Austin holds 126,839 Restricted Rights directly. Additionally, through Austin Superannuation Pty Ltd as trustee for the Brian Austin S\/F A\/C — a director-related entity — he holds 11,271,953 ordinary shares indirectly. This substantial indirect holding aligns his interests closely with those of AMA Group shareholders.<\/p>
The combination of direct Restricted Rights and significant indirect ordinary shares provides Austin with both long-term equity incentives and a meaningful economic stake. The company has not disclosed vesting schedules, performance conditions, or conversion ratios for the Restricted Rights, leaving their ultimate value contingent on those terms.<\/p>
Anthony Clark’s Holdings Across Multiple Entities<\/h2>
Following the grant, Tony Clark’s direct Restricted Rights increased to 91,962 from 19,182. His indirect interests include 467,356 ordinary shares held via the Clark Family Super Fund (registered to Mr Anthony James Clark and Mrs Denise Maree Clark) and 306,748 ordinary shares held through Clojack Pty Ltd operating as the Clojack Family A\/C, both director-related entities. These ordinary shareholdings remain unchanged post-grant.<\/p>
The company’s filing notes Clark’s last director interest notice was lodged on 25 June 2026, indicating frequent disclosures in recent months. Investors tracking insider activity may find this detail relevant when monitoring changes in his overall holdings.<\/p>
Functioning of AMA Group’s Non-Executive Director Equity Plan<\/h2>
The plan permits AMA Group to fulfill director fee obligations by issuing Restricted Rights instead of cash payments. This approach conserves cash resources while aligning directors’ incentives with the company’s long-term share price performance, a practice increasingly common among ASX-listed firms.<\/p>
Restricted Rights typically involve conditions such as holding locks, vesting periods, or performance hurdles before conversion to ordinary shares. The company has not disclosed specific terms for the 3 July 2026 grants, including vesting or conversion details. Interested investors should consult the plan documentation approved at the November 2025 AGM or await further company disclosures.<\/p>
Compliance With ASX Listing Rules and Disclosure Obligations<\/h2>
Both grants occurred outside any ASX-defined closed periods requiring prior written clearance, ensuring compliance with the company’s securities trading policies. The disclosures were made under ASX Listing Rule 3.19A.2 and section 205G of the Corporations Act, fulfilling AMA Group’s obligation to promptly notify changes in directors’ relevant interests.<\/p>
Implications for AMA Group’s Board Remuneration Strategy<\/h2>
The acceptance of Restricted Rights by Brian Austin and Tony Clark in lieu of cash fees, facilitated through a shareholder-approved plan, reflects a remuneration philosophy emphasizing equity ownership among non-executive directors. This alignment encourages governance decisions that benefit long-term shareholders.<\/p>
For investors, the directors’ choice of equity over cash signals confidence in AMA Group’s prospects, though the grants represent a continuation of an established remuneration framework rather than a new discretionary exposure increase.<\/p>
Context Within AMA Group’s Automotive Aftercare Operations<\/h2>
AMA Group operates in the automotive aftercare sector, focusing on vehicle collision repair services in Australia. The company has experienced strategic and operational changes recently, with non-executive director composition and remuneration under investor scrutiny. The simultaneous filing of director interest notices for Austin and Clark aligns with the company’s equity plan grant schedule.<\/p>
Investors may look to upcoming financial reports for insights into how the equity plan affects AMA Group’s cost structure and remuneration expenses. The grants represent non-cash accounting expenses impacting share-based payment disclosures. The company did not disclose the monetary value of the 3 July 2026 Restricted Rights grants.<\/p>
Looking Ahead: Vesting and Future Disclosures<\/h2>
Investors should monitor announcements regarding any vesting or conversion events related to the Restricted Rights held by Brian Austin and Tony Clark. Upon vesting, further disclosures such as Appendix 3Y notices would confirm conversion into ordinary shares, potentially increasing their shareholdings and influencing market activity.<\/p>
Additionally, future participation by other directors in the Non-Executive Director Equity Plan will indicate the plan’s broader adoption. Material amendments to the plan’s terms or grant sizes would require disclosure and possibly shareholder approval. The immediate market impact of these notices was not evident from available information.<\/p>
